INTRODUCTION
Rational use of medicines can help increase longevity and quality of life for individuals. However, medication use without due care especially among the chronically-ill, aging population is associated with suboptimal clinical outcomes and increased risks of drug-related problems (DRPs), resulting in preventable personal suffering and costly health expenditures. Pharmaceutical care provided by pharmacists is considered as one of the key practice to alleviate the risks of DRPs [1, 2] . In 1990, Hepler and Strand formulated the concept of pharmaceutical care , defining it as "the responsible provision of drug therapy for the purpose of achieving definite outcomes which improve a patient's quality of life" [3] . This vision was shared by many countries and professional groups around the world as a milestone for professional development. More and more pharmacists have become increasingly patientfocused and proactive in acting responsibly to optimize clinical outcome of pharmacotherapy and to minimize associated risks. In the US, European countries, Canada and New Zealand, pharmaceutical care has been well integrated into most pharmacists' routine practice [4] [5] [6] . Benefits of pharmaceutical care have been fully demonstrated in terms of clinical outcome and many other aspects such as patients' compliance, health literary and disease screening [7] [8] [9] [10] [11] [12] [13] [14] .
Depending on the legal, political and health care systems, different forms and levels of pharmaceutical care development and adoption have been observed across countries [8] . In pursuit of continuous advancement, research efforts have been made to identify possible barriers hindering the development of this professional service. Similar set of barriers have been found in many countries, the significance of each barrier varied greatly, which warrants approach and policy specific to the national situation. For instance in the US, lack of reimbursement system was considered the most important barrier [15, 16] whereas in Iran and Pakistan, ambiguity about the professional role of pharmacists and the concept of pharmaceutical care were found to limit the development of pharmaceutical care service [17, 18] .
Despite increasing concerns over DRPs, the extent of pharmaceutical care provision and possible barriers in Macao has never been examined before. The objectives of this study were to examine the pharmacists' level of understanding of pharmaceutical care, their attitude towards and current practice of the service, and the perceived barriers. It is anticipated that the study will put forward recommendations on how to advance the service in areas where pharmaceutical care is only at the early stage of development.
EXPERIMENTAL

Study design
The conceptual framework used to design this questionnaire was based on the pharmaceutical care model found in the literature [3] . A similar study [19] was also consulted and special elements unique to the business environment of community pharmacies in Macao considered when designing the semi-structured questionnaire.
Setting
Macao has a population of 600,000 and was used as the study target. It is a small city where East meets West in almost every aspect including pharmacy practice. Pharmacy practice in the city has undergone dramatic changes since its reversion to China in 1999. The number of community pharmacies increased from 46 in 2003 to 193 in 2013 and the number of registered pharmacists increased from 89 to 381 during the same period of time. The legal responsibilities of registered pharmacists still confined to dispensing, medicine storing and providing, and quality and bio-chemical analysis of drug products. However, concerns over DRPs are increasing due to aging population, over-use of medications, poly-doctor, self-medications, and concurrent use of conventional medicine and traditional medicines.
Data collection
The study was conducted in community pharmacies in Macao from January to February 2014. Personal visit by researchers at randomlyselected community pharmacies was used to distribute and retrieve self-administered questionnaires completed by community pharmacists.
Study instrument
The questionnaire was developed originally in English. Considering that Chinese would be the first language of most respondents, the questionnaire was translated into Chinese by the authors. The English content was kept for respondents' reference to original expressions of the questions. A pre-test of the questionnaire was carried out with the participation of 5 community pharmacists to assess the appropriateness of wordings and format of the questionnaire. Minor modifications were made based on their comments to achieve the final version of the questionnaire.
The questionnaire consisted of five sections. The first section collected demographic data of the respondents such as gender, age, type of pharmacy they were practising, number of years of working experiences in pharmacy, highest pharmacy-related qualification, and prescription volume. In the second section, pharmacists were questioned about six statements regarding the concept, purpose and procedures of pharmaceutical care, and the role of pharmacists on this matter. A 5-point Likert scale was adopted as the statement rating system ranging from 1 -not at all to 5 = very much. The third section consisted of 7 questions about pharmacists 'attitudes to pharmaceutical care. The fourth section asked about the frequency of the nine pharmaceutical care activities pharmacists performed during their daily practice using the scale 1 = never through 5 = always. These activities included DRP identification, DRP solving, follow-up evaluation, documentation in practice, health education, etc. In the last section, there were 11 questions regarding the barriers to the provision of pharmaceutical care in Macao. These barriers included lack of time, inadequate communication with doctors, lack of supportive policies, etc. In the third and last section, the 5-point Likert scale was used again by the pharmacists to express the level of agreement to the statements regarding their perceptions and barriers, where 1 = strongly disagree to 5 = strongly agree.
Data analysis
SPSS 20.0 was used for data analysis. In the first section, the demographic data of the respondents were analysed using descriptive statistics. For the core of this study, which is sections 2 to 5, in addition to descriptive statistics, means was also used to determine the overall response of the respondents. Reliability of the scale used was tested using Cronbach's alpha (minimum 0.5, ideally between 0.7 -0.8). In addition, ANOVA was used to perform integrative analysis of the demographic data of the respondents collected in section 1 and the data collected in the core part of study to infer any association between the background of the pharmacists and their perceptions about pharmaceutical care.
Ethical approval
The research was reviewed and approved by the Ethic Committee of University of Macau.
RESULTS
Demographics
Of the total of 107 questionnaires sent out in the survey, 102 responses were received giving a response rate of 95.3 %. Among the received responses, two of them were not completed and were thus excluded. 100 responses were included in data analysis, giving a final response rate of 93.5 %. Demographic data of the respondents are listed in Table 1 . The majority of the respondents were female (61 %), aged between 21 -30 years (84 %), worked in chain pharmacies (more than 4 stores owned by the same organization) (73 %), had only worked for < 5 years compared to > 10 years (9 %), and held a bachelor degree as the highest pharmacyrelated qualification. In other words, most of the community pharmacists in Macao were new female graduates and work in chain pharmacies with limited practice experiences.
The proportions of workload related to prescription medicines were found to be "less than 10 %" for 42 % of respondents, "11 -20 %" for 14 % of respondents, "21 -40 %" for 13 % of respondents, "41 -50 %" for 9 % of respondents and " more than 50 %" for 22 % of respondents. This data indicated a two-end distribution of job responsibility of prescription medicines. The low workload proportion in handling prescription medicines partly reflected the fact that many pharmacies in Macao served tourists mainly, which applied to the majority of the respondents 'workplace. For the pharmacists who were able to dedicate 50 % workload to prescription medicines, the pharmacies were considered as prescription medicines oriented which usually participated in the government medicinesubsidizing scheme. This represented 22 % of the respondents' workplace. All the other pharmacies where the respondents worked were considered as neighbouring pharmacies.
Pharmacists' understanding of pharmaceutical care Table 2 shows the respondents' understanding of the concept of pharmaceutical care. Although respondents' understanding of the purpose of use of pharmaceutical care was satisfactory as shown in their responses to statements 2 and 4, their comprehension of the key attitude which is the responsible provision of pharmaceutical care was only acceptable with only 70 % respondent agreeing to Statement 1. The confusion about their roles in pharmaceutical care was further indicated as only 58 % respondents believed that all patients taking medicines require pharmacists' help. Statements 3 and 6 were the two false items to test the respondents 'replies. Table 2 also shows that the respondents had higher agreement on Statement 2 (Mean = 4.39), and Statement 4 (Mean = 4.09). Cronbach's alpha over the 6 statements was 0.509. Pharmacists' attitudes to pharmaceutical care Table 3 illustrates the results of respondents 'attitudes to pharmaceutical care. The respondents generally had a positive attitude and good determination to the provision of pharmaceutical care, 95 % of them agreed that patients' health was their primary responsibility and would try their best to provide patients with the most suitable medicine as shown in their responses to statements 1 and 2. The results of statements 5 and 7 also indicated that 89 % of them were willing to provide the service and 98 % acknowledged the expectations of the patients. 79 % of them were already conscious about the economy factor when choosing suitable medicines for their patients and 87 % considered the provision of quality pharmaceutical care a source of job satisfaction as shown by the responses to statements 3 and 6. However, only 57 % of the respondents believed that they could provide more comprehensive pharmaceutical care in the future. Table 3 also shows that the respondents had the highest agreement on Statement 2 (Mean = 4.42). Comparatively, they showed the lowest agreement on Statement 4 (Mean = 3.74). Cronbach's alpha over the 7 statements was 0.763. Table 4 lists the results of respondents 'perceived frequency of pharmaceutical care provision in their daily practice. 85-90 % of the respondents spent considerable amount of time counselling with patients, instructing them about drug administration, dosage, and precautions, and providing general health information and medication information. Around 70 % of the respondents reported that they spent some of the time or most of their time performing prescription checks and conducting health education. Only 44 % of the respondents monitored adverse drug reaction and drug compliance among patients as part of their usual practice. Less than 20 % of the respondents engaged in health screening activities or drug safety promotion outside community pharmacy setting. Only 4 % of the respondents created personal medication record. As shown in Table 4 , the respondents had the highest agreement on Statement 1 (Mean = 4.16) and Statement 3 (Mean = 4.16). Comparatively, they expressed the much lower agreement on Statement 6 (Mean = 1.41), Statement 5 (Mean = 1.94), and Statement 9 (Mean = 1.99). Cronbach's alpha over the 9 statements was 0.744. Table 5 lists the respondents' opinions on the possible factors that might have inhibited the provision of pharmaceutical care. Over 90 % of the respondents agreed or strongly agreed that insufficient communication with physician was a barrier. 79 % of the respondents expressed that lack of physical space for pharmaceutical care provision was the second factor. Lack of time to provide pharmaceutical care (76 %), lack of patient acceptance of pharmaceutical care (71 %), lack of compensation for pharmaceutical care provision (68 %), slow introduction of pharmacist law (66 %), and lack of face-to-face communication with patient (55 %) were also considered important factors by the respondents. However, less than 40 % of the respondents thought that lack of support to pharmaceutical care from pharmacy owners (37 %), lack of effective communication skills (36 %), lack of support to pharmaceutical care from other health care professionals (33 %) and lack of knowledge about drug use (29 %) were highly relevant barriers. Table 5 also shows that the respondents had the highest agreement on Statement 9 (Mean = 4.31) but the lowest agreement on Statement 7 (Mean = 2.72).
Perceived frequency of pharmaceutical care provision
Perceived barriers to the provision of pharmaceutical care
In the ANOVA analysis, no significant findings indicating that there is no association between the background of the pharmacists and their perceptions about pharmaceutical care were observed. 
DISCUSSION
A typical pharmacist in Macao would most likely be a young female, who held a bachelor degree in Pharmacy and practised for only a few years, spending more than half of her working hours on duties unrelated to prescription medicines. The high response rate to the questionnaire (95.3 %) indicated a common interest in pharmaceutical care and younger pharmacists might imply a higher level of acceptance and understanding of the professional service [4] . Many of them also showed a satisfactory understanding of the overall concept of pharmaceutical care. Nevertheless, a low level of pharmaceutical care was also observed. Less than 75 % fully recognized the need to act proactively which might profoundly jeopardize the development of pharmaceutical care [17] . When performing pharmaceutical care, respondents spent a lot of time trying to identify DRPs for the patients but they hardly evaluated or even challenged doctors' prescriptions. There was literally no documentation of pharmaceutical practice and health education was only confined to the pharmacy setting which could explain why the pharmaceutical care processes often ended after the pharmacists' first encounter with their patients as shown in another study [20] .
More than 40 % of the respondents did not think that they could provide more comprehensive pharmaceutical care, indicating that there were challenges they were unable to resolve on their own. Similar to the result of previous studies, insufficient communication with physicians, lack of physical space, lack of time and lack of patient acceptance were reported to be the most important barriers by the respondents [4, 9, 21] . Lack of compensation mechanism for the service, lack of supportive policies and lack of time and opportunity to communicate with patients were also considered significant. Only 58 % of the respondents thought all patients taking medicines would require pharmacists' help, reflecting a low level of reliance by patients on pharmacists 'professional service.
Taking into account other countries' experiences, the delayed development of pharmaceutical care could be explained by a lack of supportive policies and/or standards of practice to clearly define and mandate the professional obligations in the provision of pharmaceutical care as part of their essential practice. Without the necessary legal framework, neither the pharmacists nor other health care professionals could fully comprehend the importance of the pharmacist profession and the pharmaceutical care. This in turn posed a negative impact on doctors' acceptance of the service and willingness to communicate with pharmacists about patient's medication and health records. Patients for the same reason would not be keen in disclosing their medicine use with pharmacists and expecting any intervention. At the same time, pharmacy owners would not be motivated to adjust the physical environment in the pharmacy to appropriately accommodate the provision of the service. At the moment, pharmacists rarely had a chance to provide the service comprehensively. Without sufficient opportunities to practice, collection of data demonstrating the benefits of the service would be difficult. Until the cost and benefit of pharmaceutical care service can be justified with solid evidence, there is no condition for negotiation of a compensation mechanism for such service. Without reasonable financial incentives, pharmacy owners would not be motivated to incorporate the service into their business and to make manpower arrangement to free pharmacists out, from day-to-day front of shop duties to become dedicated to professional services.
Although lack of effective communication skills and lack of appropriate knowledge were not highly regarded as the major barriers by the respondents, they were rated the major barriers in other studies [22] [23] [24] [25] . In this study, either the pharmacists had enough communication skills and clinical knowledge or they did not have enough practice opportunity to realize their shortcomings and the impact thereof on the provision of pharmaceutical care. Nevertheless, this area should be examined further for reassurance.
Limitations of the study
The study has several limitations. The current study was developed based on a thorough literature review. The questionnaire design was based on the theoretical basis of studies alike carried out abroad which may not fully address the situations specific to Macao and undermine the associated uncertainties of the results. Another limitation is the relatively small sample size of 100. Although it is proportionally significant given the Macao pharmacist workforce of 381, the sample size may not be sufficient to minimize bias and may prevent precise generalization of the results. This study did not take into account the effect of the pharmacy business mode which has been reported as an influential factor in some studies. Subgroup analyses between the different types of pharmacies using a large sample size may be performed in the future to resolve this limitation.
CONCLUSION
Pharmacists in Macao have very positive attitude towards the provision of the service in the best interests of the patients and of the profession. However, there is a lack of responsibility to act proactively to provide the service and only some aspects of pharmaceutical care are currently conducted in their daily practice. Similar to findings in other studies, multiple perceived barriers are revealed, including insufficient communication with physicians, lack of working space, lack of time and lack of patient acceptance as the major ones. In the context of pharmacy practice situation in Macao, implementation of supportive policies and collection of evidence to demonstrate the benefits of pharmaceutical care are considered the foremost steps to alleviate the barriers for the service to leap forward from the infancy stage.
